聚焦超声介导血脑屏障通透性增加的声学监测与控制进展
经颅聚焦超声联合静脉微泡可短暂、选择性增加血脑屏障通透性,实现中枢神经系统靶向给药,目前已在脑肿瘤、早期阿尔茨海默病和肌萎缩侧索硬化患者中开展临床测试。本综述概述了超声刺激微泡的振荡动力学、声发射和生物学效应,总结了基于声学的微泡活动检测、控制和成像策略进展,并指出需进一步开发面向微泡介导应用的新一代临床聚焦超声脑设备。
要点
- 经颅聚焦超声联合静脉微泡可短暂、选择性开放血脑屏障,用于中枢神经系统靶向给药。
- 临床测试已在脑肿瘤、早期阿尔茨海默病和肌萎缩侧索硬化患者中开展。
- 实时治疗监测与控制是推广该技术的关键挑战,需确保安全有效的声学暴露水平。
核心结论
- 聚焦超声介导血脑屏障通透性增加具有变革神经系统疾病治疗方式的潜力,但需进一步开发面向微泡介导应用的新一代临床聚焦超声脑设备以实现常规临床转化。
研究设计与样本
- 综述,总结超声刺激微泡的振荡动力学、声发射和生物学效应,以及基于声学的微泡活动检测、控制和成像策略进展。
局限性
- 实时治疗监测与控制是广泛临床采用聚焦超声介导血脑屏障通透性增加所需解决的主要挑战。
- 需进一步开发面向微泡介导应用的新一代临床聚焦超声脑设备以推动临床转化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Transcranial focused ultrasound (FUS) combined with intravenously circulating microbubbles can transiently and selectively increase blood-brain barrier permeability to enable targeted drug delivery to the central nervous system, and is a technique that has the potential to revolutionize the way neurological diseases are managed in medical practice. Clinical testing of this approach is currently underway in patients with brain tumors, early Alzheimer's disease, and amyotrophic lateral sclerosis. A major challenge that needs to be addressed in order for widespread clinical adoption of FUS-mediated blood-brain barrier permeabilization to occur is the development of systems and methods for real-time treatment monitoring and control, to ensure that safe and effective acoustic exposure levels are maintained throughout the procedures. This review gives a basic overview of the oscillation dynamics, acoustic emissions, and biological effects associated with ultrasound-stimulated microbubbles in vivo, and provides a summary of recent advances in acoustic-based strategies for detecting, controlling, and mapping microbubble activity in the brain. Further development of next-generation clinical FUS brain devices tailored towards microbubble-mediated applications is warranted and required for translation of this potentially disruptive technology into routine clinical practice.
引用
- Jones RM, Hynynen K. Advances in acoustic monitoring and control of focused ultrasound-mediated increases in blood-brain barrier permeability. Br J Radiol. 2019. PMID: 30507302. doi:10.1259/bjr.20180601
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。